Efficacy and Effectiveness of a 23-Valent Polysaccharide Vaccine Against Invasive and Non-Invasive Pneumococcal Disease and Related Outcomes: A Review of Available Evidence
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Effectiveness of a 23-Valent Polysaccharide Vaccine Against Invasive and Non-Invasive Pneumococcal Disease and Related Outcomes: A Review of Available Evidence
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2021-01-22
DOI
10.1080/14760584.2021.1880328
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
- (2020) Jacob Dag Berild et al. Pathogens
- Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus “no vaccination” and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine
- (2019) Miguel Gouveia et al. Human Vaccines & Immunotherapeutics
- Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
- (2019) Joshua P. Metlay et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain
- (2019) A. González-Díaz et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015–2016
- (2019) Angel Vila-Corcoles et al. VACCINE
- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
- (2019) Almea Matanock et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017
- (2019) Shinthuja Wijayasri et al. PLoS One
- Cost-effectiveness of continuing pneumococcal conjugate vaccination at age 65 in the context of indirect effects from the childhood immunization program
- (2019) Charles Stoecker et al. VACCINE
- The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage
- (2018) Pilar Ciruela et al. VACCINE
- Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia
- (2018) C. Chen et al. VACCINE
- Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination
- (2018) Germaine Hanquet et al. THORAX
- Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study
- (2017) Motoi Suzuki et al. LANCET INFECTIOUS DISEASES
- Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly – Selection of controls in a case-control study
- (2017) Kyoko Kondo et al. VACCINE
- Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations
- (2017) Yang Wang et al. Human Vaccines & Immunotherapeutics
- Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
- (2017) Gerhard Falkenhorst et al. PLoS One
- Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors
- (2016) Erik Backhaus et al. BMC INFECTIOUS DISEASES
- Pneumococcal pneumonia in adults 60 years or older: Incidence, mortality and prevention
- (2016) Angel Vila-Corcoles et al. MEDICINA CLINICA
- Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly
- (2016) Chia-Sheng Kuo et al. MEDICINE
- Burden of four vaccine preventable diseases in older adults
- (2016) Maartje Kristensen et al. VACCINE
- The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis
- (2016) Hannah Kraicer-Melamed et al. VACCINE
- Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials
- (2016) Wen-qi Diao et al. VACCINE
- The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old—Taiwan's PPV vaccination program
- (2015) Ying-Huang Tsai et al. VACCINE
- Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
- (2015) Kiyoshi Migita et al. ARTHRITIS RESEARCH & THERAPY
- Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study
- (2014) O. Ochoa-Gondar et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008–2011
- (2014) M A Gutiérrez Rodríguez et al. Eurosurveillance
- Sex differences in injection site reactions with human vaccines
- (2014) Ian F. Cook Human vaccines & immunotherapeutics
- Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults
- (2014) John D. Grabenstein et al. VACCINE
- The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study
- (2014) Timothy L. Wiemken et al. VACCINE
- Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
- (2014) Kimberly M. Shea et al. Open Forum Infectious Diseases
- Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques
- (2013) Maria A. Said et al. PLoS One
- Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011
- (2013) Wallis Rudnick et al. VACCINE
- Immunosenescence and pneumococcal disease: an imbalance in host–pathogen interactions
- (2013) Cassandra L Krone et al. Lancet Respiratory Medicine
- Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
- (2012) Angel Vila-Corcoles et al. BMC PUBLIC HEALTH
- A century of pneumococcal vaccination research in humans
- (2012) J.D. Grabenstein et al. CLINICAL MICROBIOLOGY AND INFECTION
- Streptococcus Pneumoniae Urinary Antigen Test and Acute Exacerbations of Chronic Obstructive Pulmonary Disease
- (2012) Koichi Nishimura et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes
- (2012) Albert Jan van Hoek et al. PLoS One
- Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study
- (2012) Rulin C. Hechter et al. VACCINE
- Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales
- (2012) Nick J. Andrews et al. VACCINE
- Laboratory-based diagnosis of pneumococcal pneumonia: state of the art and unmet needs
- (2011) G. Vernet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe
- (2011) David S Fedson et al. Expert Review of Vaccines
- Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
- (2010) Angel Vila-Corcoles et al. BMC INFECTIOUS DISEASES
- The Xs and Y of immune responses to viral vaccines
- (2010) Sabra L Klein et al. LANCET INFECTIOUS DISEASES
- Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species
- (2008) Mathias W. Pletz et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now